BSI’s Post

💊 Three very different pharmaceutical products. All assessed using the same framework. GSK, Sanofi and Novo Nordisk each piloted PAS 2090 on a marketed product, and in this on-demand session, they share what that process looked like in practice: 🔬 GSK on applying PAS 2090 to an oncology therapy 💉 Sanofi on piloting the standard with a Haemophilia A medicine 🖊️ Novo Nordisk on assessing an insulin prefilled multidose pen for the European market 📋 Key lessons on data availability, supplier engagement and assessment timelines Three pilots. Three sets of lessons. One emerging industry standard. 🔗 Explore the manufacturer case studies: https://lnkd.in/efQAdy8J #BSI #PAS2090 #Pharma #Sustainability #LCA #LifecycleAssessment